Patents by Inventor Thomas G. Martin, III

Thomas G. Martin, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB
    Publication number: 20220088194
    Abstract: Disclosed herein are compositions and kits which comprise anti-CD38 antibodies and carfilzomib compounds. Also disclosed are methods for treating cancers, such as multiple myeloma, in subjects with the compositions and kits.
    Type: Application
    Filed: May 19, 2021
    Publication date: March 24, 2022
    Inventors: Blake TOMKINSON, Blake T. AFTAB, Byron C. HANN, Thomas G. MARTIN, III
  • COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND LENALIDOMIDE
    Publication number: 20200046832
    Abstract: Disclosed herein are compositions and kits which comprise anti-CD38 antibodies and lenalidomide compounds. Also disclosed are methods for treating cancers, such as multiple myeloma, in subjects with the compositions and kits.
    Type: Application
    Filed: June 5, 2019
    Publication date: February 13, 2020
    Inventors: Byron C. HANN, Blake TOMKINSON, Thomas G. MARTIN, III, Blake T. AFTAB
  • COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB
    Publication number: 20190321471
    Abstract: Disclosed herein are compositions and kits which comprise anti-CD38 antibodies and carfilzomib compounds. Also disclosed are methods for treating cancers, such as multiple myeloma, in subjects with the compositions and kits.
    Type: Application
    Filed: April 4, 2019
    Publication date: October 24, 2019
    Inventors: Blake TOMKINSON, Blake T. AFTAB, Byron C. HANN, Thomas G. MARTIN, III
  • Compositions comprising anti-CD38 antibodies and lenalidomide
    Patent number: 10342869
    Abstract: Disclosed herein are compositions and kits which comprise anti-CD38 antibodies and lenalidomide compounds. Also disclosed are methods for treating cancers, such as multiple myeloma, in subjects with the compositions and kits.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: July 9, 2019
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SANOFI
    Inventors: Byron C. Hann, Blake Tomkinson, Thomas G. Martin, III, Blake T. Aftab
  • COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB
    Publication number: 20170106085
    Abstract: Disclosed herein are compositions and kits which comprise anti-CD38 antibodies and carfilzomib compounds. Also disclosed are methods for treating cancers, such as multiple myeloma, in subjects with the compositions and kits.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 20, 2017
    Inventors: Blake TOMKINSON, Blake T. AFTAB, Byron C. HANN, Thomas G. MARTIN, III
  • COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB
    Publication number: 20160022813
    Abstract: Disclosed herein are compositions and kits which comprise anti-CD38 antibodies and carfilzomib compounds. Also disclosed are methods for treating cancers, such as multiple myeloma, in subjects with the compositions and kits.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: Blake TOMKINSON, Blake T. AFTAB, Byron C. HANN, Thomas G. MARTIN, III
  • Compositions Comprising Anti-CD38 Antibodies and Lenalidomide
    Publication number: 20140161819
    Abstract: Disclosed herein are compositions and kits which comprise anti-CD38 antibodies and lenalidomide compounds. Also disclosed are methods for treating cancers, such as multiple myeloma, in subjects with the compositions and kits.
    Type: Application
    Filed: December 6, 2013
    Publication date: June 12, 2014
    Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SANOFI
    Inventors: Byron C. Hann, Blake Tomkinson, Thomas G. Martin, III, Blake T. Aftab